InnoCan Pharma Financial Overview
InnoCan Pharma's market cap is currently C$33.74M. The company's EPS TTM is C$-0.596; its P/E ratio is -7.50; InnoCan Pharma is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
